Showing results (621-630 of 1,609) with videos related to
Sort By:
Pageof 161
JAMA Oncology|July 12, 2019
Value of Molecular Classification for Prognostic Assessment of Adrenocortical CarcinomaGuillaume Assié, Anne Jouinot, Martin Fassnacht, et al.JAMA Oncology|July 12, 2019
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 TrialJoshua M Bauml, Rosemarie Mick, Christine Ciunci, et al.JAMA Oncology|August 25, 2022
World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A ReviewTamar R Berger, Patrick Y Wen, Melanie Lang-Orsini, et al.JAMA Oncology|September 30, 2021
Geriatric Assessment-Driven Intervention (GAIN) on Chemotherapy-Related Toxic Effects in Older Adults With Cancer: A Randomized Clinical TrialDaneng Li, Can-Lan Sun, Heeyoung Kim, et al.JAMA Oncology|September 30, 2021
Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian CancerAlexander Melamed, J Alejandro Rauh-Hain, Allison A Gockley, et al.JAMA Oncology|February 24, 2022
Palliative Radiation for Advanced Central Lung Tumors With Intentional Avoidance of the Esophagus (PROACTIVE): A Phase 3 Randomized Clinical TrialAlexander V Louie, Patrick V Granton, Alysa Fairchild, et al.JAMA Oncology|February 17, 2022
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling AnalysisKathryn P Lowry, H Amarens Geuzinge, Natasha K Stout, et al.JAMA Oncology|February 17, 2022
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical TrialGuo-Ying Liu, Wang-Zhong Li, De-Shen Wang, et al.JAMA Oncology|January 27, 2022
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes, Nasim Mavaddat, Leila Dorling, et al.JAMA Oncology|January 27, 2022
Geospatial Disparities in the Treatment of Curable Breast Cancer Across the USMichael J Hassett, Angela C Tramontano, Hajime Uno, et al.Pageof 161